Income Tax Expense (Benefit) of GYRE THERAPEUTICS, INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GYRE THERAPEUTICS, INC. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • GYRE THERAPEUTICS, INC. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $1,693,000, a 58% increase year-over-year.
  • GYRE THERAPEUTICS, INC. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $3,459,000, a 41% decline year-over-year.
  • GYRE THERAPEUTICS, INC. annual Income Tax Expense (Benefit) for 2024 was $5,320,000, a 38% decline from 2023.
  • GYRE THERAPEUTICS, INC. annual Income Tax Expense (Benefit) for 2023 was $8,515,000, a 67% increase from 2022.
  • GYRE THERAPEUTICS, INC. annual Income Tax Expense (Benefit) for 2022 was $5,098,000.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

GYRE THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,459,000 $1,693,000 +$619,000 +58% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,840,000 $662,000 -$835,000 -56% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $3,675,000 $901,000 -$1,645,000 -65% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $5,320,000 $203,000 -$496,000 -71% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 $5,816,000 $1,074,000 -$2,604,000 -71% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $8,420,000 $1,497,000 -$587,000 -28% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $9,007,000 $2,546,000 +$492,000 +24% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $8,515,000 $699,000 -$4,399,000 -86% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $12,914,000 $3,678,000 +$3,678,000 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $9,236,000 $2,084,000 +$2,084,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $7,152,000 $2,054,000 +$2,054,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $5,098,000 $5,098,000 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 $0 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2015 $93,000 $21,000 -$3,391,000 -99% 01 Jan 2015 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $3,484,000 $16,000 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
Q3 2014 $11,000 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $45,000 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015 2015 Q2
Q1 2014 $3,412,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q3 2012 $0 $0 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $0 $0 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q3 2011 $0 -$257,000 -100% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012 2012 Q3
Q2 2011 $0 -$1,512,000 -100% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q3 2010 $257,000 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 $1,512,000 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011 2011 Q2

GYRE THERAPEUTICS, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $5,320,000 -$3,195,000 -38% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $8,515,000 +$3,417,000 +67% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $5,098,000 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2014 $3,484,000 +$3,477,000 +49671% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
2013 $7,000 +$108,000 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
2012 $101,000 -$101,000 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $0 -$3,526,000 -100% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
2010 $3,526,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.